
CMS will be changing reimbursement practices regardless of how healthcare reform plays out

CMS will be changing reimbursement practices regardless of how healthcare reform plays out

The most basic impulse behind CER is the desire to control healthcare costs. The implications for the biopharma industry could be significant

Published: August 22nd 2009 | Updated:

Published: April 10th 2010 | Updated: